WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 06-02-2024
Asset Class:
Benchmark: BSE Healthcare TRI
Expense Ratio: 2.39% As on (30-11-2024)
Status: Open Ended Schemes
Minimum Investment: 100.0
Minimum Topup: 100.0
Total Assets: 254 Cr As on (30-11-2024)
Turn over:
NAV as on 20-12-2024

13.358

-0.12 (-0.8834%)

CAGR Since Inception

32.63%

BSE Healthcare TRI 15.47%

PERFORMANCE of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Scheme Performance (%) Data as on - 20-12-2024

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth - - - - 32.63
Benchmark - - - - -
Equity: Sectoral-Pharma and Healthcare 42.48 21.9 27.72 14.27 23.87

Yearly Performance (%)

Nav Movement

Fund Managers

Piyush Baranwal, Ramesh Mantri, Dheeresh Pathak

Investment Objective

The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

RETURNS CALCULATOR for WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth - - - - - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Period
Data as on - 20-12-2024
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth 06-02-2024 0.0 0.0 0.0 0.0 0.0
HDFC Pharma and Healthcare Fund - Growth Option 05-10-2023 51.93 0.0 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 49.14 42.19 25.88 30.29 0.0
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 46.79 33.15 18.73 23.24 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 45.36 38.84 22.11 27.61 13.24
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 44.94 34.91 20.91 0.0 0.0
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 42.39 39.04 25.29 29.37 14.05
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 42.34 36.2 22.77 27.39 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 41.56 37.05 23.06 30.9 0.0
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 40.87 34.25 19.81 28.75 0.0

PORTFOLIO ANALYSIS of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Asset Allocation (%)